These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 64419)

  • 1. [The appearance of anti-thrombocyte and anti-leukocyte antibodies in hemophilia A patients after cryoprecipitate transfusions].
    Uteg KH; Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(5):771-6. PubMed ID: 64419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Appearance of anti-c (anti-hr') antibodies in combination with anti-leukocyte antibodies in patient with hemophilia].
    Burlachenko IS; Zhukova NA
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):49-51. PubMed ID: 4981802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis-associated antigen and antibodies after multiple transfusions in children and juveniles with severe and moderately severe haemophilia (author's transl)].
    Schwartz B; Landbeck G
    Dtsch Med Wochenschr; 1973 Oct; 98(43):2016-9. PubMed ID: 4744372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antileukocytic and antithrombocytic antibodies in children following a single exposure to extracorporeal circulation].
    Kubíková-Kourilová A
    Cesk Pediatr; 1969 May; 24(5):396-400. PubMed ID: 5790753
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocyte subpopulations in the hemophilia A population at the La Coruña regional hospital].
    Martínez Cadorniga E; Rodríguez Fernández JM
    Sangre (Barc); 1986; 31(1):83-9. PubMed ID: 3085244
    [No Abstract]   [Full Text] [Related]  

  • 7. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 9. [The appearance of leukocyte and thrombocyte antibodies in internal diseases].
    Leverenz S; Konrad H; Schulz K; Nowotny P
    Allerg Asthma (Leipz); 1969; 15(3):129-40. PubMed ID: 4984399
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
    Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus.
    Koerper MA; Kaminsky LS; Levy JA
    Lancet; 1985 Feb; 1(8423):275. PubMed ID: 2857339
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and persistence of antibody to hepatitis-associated (Australia) antigen in patients with hemophilia.
    Seeler RA; Mufson MA
    J Infect Dis; 1971 Mar; 123(3):279-83. PubMed ID: 5000075
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemophilia home transfusion program: effect of cryoprecipitate utilization.
    Lazerson J
    J Pediatr; 1973 May; 82(5):857-9. PubMed ID: 4698962
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
    Kamiya T
    Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
    [No Abstract]   [Full Text] [Related]  

  • 15. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
    Peerlinck K; Arnout J; Gilles JG; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1993 Feb; 69(2):115-8. PubMed ID: 8456422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic abnormalities in patients with hemophilia A.
    Weintrub PS; Koerper MA; Addiego JE; Drew WL; Lennette ET; Miner R; Cowan MJ; Ammann AJ
    J Pediatr; 1983 Nov; 103(5):692-5. PubMed ID: 6415259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilia in Somalia.
    Abdulle OA; Mohamud MS; Isse MM; Chistolini A; Papacchini M; Mariani G
    Haemostasis; 1989; 19(2):100-4. PubMed ID: 2499520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to factor VIII: specificity and kinetics of iso- and hetero-antibodies in hemophilia A.
    Allain JP; Frommel D
    Blood; 1974 Sep; 44(3):313-22. PubMed ID: 4604102
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors.
    Ruggeri ZM; Mannucci PM; Allain JP; Frommel D
    Ann N Y Acad Sci; 1975 Jan; 240():412-8. PubMed ID: 1053886
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L
    ASDC J Dent Child; 1979; 46(1):54-6. PubMed ID: 283081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.